Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Background: The purpose of this study is to identify and characterize ocular adverse events (AEs) that are significantly associated with anti-VEGF drugs for treatment of neovascular age-related macular degeneration and compare the differences between each drug, and provide clinical reference. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Pan, Pan, Xinmei, Liu, Ruixiang, Qu, Ya, Xie, Linli, Xie, Jiangchuan, Cao, Liya, Chen, Yongchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716077/
https://www.ncbi.nlm.nih.gov/pubmed/36467087
http://dx.doi.org/10.3389/fphar.2022.1017889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716077/
https://www.ncbi.nlm.nih.gov/pubmed/36467087
http://dx.doi.org/10.3389/fphar.2022.1017889

Ejemplares similares